-
The Upstream and Downstream products of CyclosporinH
Time of Update: 2023-05-12
These medications are used to prevent the rejection of transplanted organs and to treat autoimmune diseases such as psoriasis and rheumatoid arthritis.
These medications are used to prevent the rejection of transplanted organs and to treat autoimmune diseases such as psoriasis and rheumatoid arthritis.
-
The Upstream and Downstream products of 3-AMINO-N-CYCLOHEXYLBENZENESULFONAMIDE
Time of Update: 2023-05-09
In conclusion, N-Cyclohexylbenzensulfonamide is a versatile intermediate chemical that is used in a variety of industries, including dyes and pigments, pharmaceuticals, agrochemicals, and research and development.
In conclusion, N-Cyclohexylbenzensulfonamide is a versatile intermediate chemical that is used in a variety of industries, including dyes and pigments, pharmaceuticals, agrochemicals, and research and development.
-
In less than a month, another subsidiary of this pharmaceutical company will be spun off and listed
Time of Update: 2023-02-01
According to public information, the listed Kelun Pharmaceutical business spans the fields of pharmaceutical research and development, drug manufacturing and commercial circulation, and is engaged in the research and development, production and sales of infusion products, innovative drugs, generic drugs and antibiotic intermediates.
-
ADC new drug R&D pattern in China
Time of Update: 2023-01-05
As of November 2022, NMPA has accepted a total of 80 new ADC drugs. Since 2020, the research and development of new ADC drugs in China has become popular and has entered a stage of explosive growth, w
-
A new method for synthesizing messenger RNA
Time of Update: 2023-01-05
Molecular Therapy - Nucleic Acids, 2022; 30: 300 A team of synthetic biologists at the Hong Kong University of Science and Technology (HKUST) recently discovered a way to increase the efficiency of protein production of synthetic mRNA by up to 10 times, meaning that with fewer mRNA doses, the effectiveness of mRNA vaccines and drugs used to treat cancer, Covid-19 or other genetic diseases can be greatly improved.
-
Agilent showcased localization and cutting-edge innovation at the 5th CIIE
Time of Update: 2023-01-04
At this Expo, Agilent's exhibits are intuitively expressing these innovative ideas - in the field of industrial and chemical analysis that Agilent is good at, the advanced mass spectrometry and gas chromatography displayed by Agilent have long been recognized as the best, they have entered countless domestic enterprise R & D departments and scientific research institutions, covering a wide range of basic research levels from raw material analysis to process control, product research and development, quality control, etc.
-
Domestic pharmaceutical companies "went overseas" to lock in the European market, and Fosun, Baekje, Junshi and others broke through
Time of Update: 2023-01-01
Going overseas is an important way for innovative pharmaceutical companies to explore new business growth points, and it is an inevitable trend for innovative biopharmaceutical companies to go overse
-
Components of the new GMP online monitoring system for sterile pharmaceutical companies
Time of Update: 2022-09-21
With the expansion of the influence of the FDA and EU GMP in China and the launch of a new version of GMP in China, the dynamic monitoring of the clean area environment of pharmaceutical companies, es
-
Under the intensive adjustment of major pharmaceutical companies, innovation is occupying an increasingly important position
Time of Update: 2022-09-09
In the industry's view, whether it is structural adjustment or personnel changes, multinational pharmaceutical companies are to better adapt to changes in the Chinese pharmaceutical market environment and focus on core business, especially in the field of innovative drugs.
-
Cash dividends, product reviews, senior executives leaving... The announcement of listed pharmaceutical companies on August 12 is interesting
Time of Update: 2022-08-20
Dirui Medical's 2022 semi-annual report shows that the company achieved operating income of 515 million yuan in the first half of the year, an increase of 23.
-
Pfizer recalls several batches of blood pressure drugs over carcinogen
Time of Update: 2022-05-14
According to Reuters, on April 22, the US pharmaceutical giant Pfizer announced that it would recall five batches of the antihypertensive drug "Akpril" .
Pfizer last month also recalled some batches and two authorized cheaper versions of another blood pressure drug, Accuretic, because it may contain carcinogens .
-
Industry: In the long run, the pharmaceutical industry is still a "long slope and thick snow" track
Time of Update: 2022-05-11
Specifically, the The fund manager believes that there are many investment opportunities in the field of innovative drugs and medical devices, because innovative products have strong explosive performance and are supported by logic such as independent innovation and import substitution .
-
Who is the "pillar" for the sales growth rate of big pharmaceutical companies
Time of Update: 2022-04-17
Recently, large multinational pharmaceutical companies have successively released their 2021 annual reports.
How is the growth of large pharmaceutical companies?
(Data sources: Annual reports of various companies, Huachuang Securities, Medical Cube, etc.
-
CSPC took the lead in buying the bottom, and the domestic Biotech selling tide is about to start
Time of Update: 2022-03-07
The inevitable result of the trend of the times Some people say that Mingkang Bio's "selling body" opened the prelude to the big pharmaceutical company's bottom-hunting Biotech, which is true .
-
The U.S. Department of Commerce announced that the sanctions list does not involve CXOs and innovative pharmaceutical companies
Time of Update: 2021-12-31
S. Department of Commerce issued a notice stating that dozens of entities located in China, Georgia, Malaysia, and Turkey were included in the Entity List, of which 34 Entities are located in China .
